Travoprost--a new prostaglandin analogue for the treatment of glaucoma (Q34706939)

4 August 2017

1 reference

title

Travoprost--a new prostaglandin analogue for the treatment of glaucoma (English)

1 reference

4 August 2017

Jess T Whitson

1

1 reference

PubMed ID

12083996

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Expert Opinion on Pharmacotherapy

4 August 2017

1 reference

4 August 2017

3

1 reference

4 August 2017

7

1 reference

4 August 2017

965-977

1 reference

Neuronal death in glaucoma

4 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Number of people with glaucoma worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Identification of a gene that causes primary open angle glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Adult-onset primary open-angle glaucoma caused by mutations in optineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Target pressure--glaucomatologists' holey grail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Compliance with ocular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Changing therapeutic paradigms in glaucoma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Effect of temperature and light on the stability of latanoprost and its clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

A comparison of intraocular pressure-lowering effect of prostaglandin F2 -alpha analogues, latanoprost, and unoprostone isopropyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

Studies on the characterisation of prostanoid receptors: a proposed classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.7.965

21 January 2018

Identifiers

DOI

10.1517/14656566.3.7.965

1 reference

release_2nkmiw3hgzc6xj2fu53glcfnqu

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2nkmiw3hgzc6xj2fu53glcfnqu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12083996

1 reference

PubMed ID

12083996